{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:39:35Z","timestamp":1785501575891,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11906-022-01199-0","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T12:03:58Z","timestamp":1653393838000},"page":"303-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["ED BP Management for Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"24","author":[{"given":"W. Denney","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7559-2982","authenticated-orcid":false,"given":"Wan-Tsu W.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"issue":"1","key":"1199_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11906-018-0805-y","volume":"20","author":"AL Hinderliter","year":"2018","unstructured":"Hinderliter AL, Voora RA, Viera AJ. Implementing ABPM into clinical practice. Curr Hypertens Rep. 2018;20(1):5. https:\/\/doi.org\/10.1007\/s11906-018-0805-y.","journal-title":"Curr Hypertens Rep"},{"issue":"20","key":"1199_CR2","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.2010.650","volume":"303","author":"BM Egan","year":"2010","unstructured":"Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008. JAMA. 2010;303(20):2043\u201350. https:\/\/doi.org\/10.1001\/jama.2010.650.","journal-title":"JAMA"},{"issue":"2","key":"1199_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990\u20132015. JAMA. 2017;317(2):165\u201382. https:\/\/doi.org\/10.1001\/jama.2016.19043.","journal-title":"JAMA"},{"issue":"5","key":"1199_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1212\/wnl.50.5.1413","volume":"50","author":"SC Johnston","year":"1998","unstructured":"Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50(5):1413\u20138. https:\/\/doi.org\/10.1212\/wnl.50.5.1413.","journal-title":"Neurology"},{"issue":"4","key":"1199_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","volume":"8","author":"VL Feigin","year":"2009","unstructured":"Feigin VL, Lawes CMM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355\u201369. https:\/\/doi.org\/10.1016\/S1474-4422(09)70025-0.","journal-title":"Lancet Neurol"},{"issue":"19","key":"1199_CR6","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1212\/WNL.0b013e3181dd42b3","volume":"74","author":"CE Lovelock","year":"2010","unstructured":"Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology. 2010;74(19):1494\u2013501. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dd42b3.","journal-title":"Neurology"},{"issue":"7","key":"1199_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1474-4422(09)70126-7","volume":"8","author":"DJ Nieuwkamp","year":"2009","unstructured":"Nieuwkamp DJ, Setz LE, Algra A, Linn FHH, de Rooij NK, Rinkel GJE. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635\u201342. https:\/\/doi.org\/10.1016\/S1474-4422(09)70126-7.","journal-title":"Lancet Neurol"},{"key":"1199_CR8","doi-asserted-by":"publisher","unstructured":"\u2022 Yokoyama S, Hifumi T, Kawakita K, Tamiya T, Minamino T, Kuroda Y. Early hyperoxia in the intensive care unit is significantly associated with unfavorable neurological outcomes in patients with mild-to-moderate aneurysmal subarachnoid hemorrhage. Shock 2019;51(5):593-8. https:\/\/doi.org\/10.1097\/SHK.0000000000001221. This retrospective study highlights early hyperoxia in ICU was significantly associated with unfavorable neurological outcomes in SAH patients with Hunt and Kosnik (H&K) grades I-III.","DOI":"10.1097\/SHK.0000000000001221"},{"issue":"3","key":"1199_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/archneur.62.3.410","volume":"62","author":"AM Naidech","year":"2005","unstructured":"Naidech AM, Janjua N, Kreiter KT, Ostapkovich ND, Fitzsimmons BF, Parra A, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62(3):410\u20136. https:\/\/doi.org\/10.1001\/archneur.62.3.410.","journal-title":"Arch Neurol"},{"key":"1199_CR10","doi-asserted-by":"crossref","unstructured":"\u2022 Sorteberg A, Romundstad L, Sorteberg W. Timelines and rebleeds in patients admitted into neurosurgical care for aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 2021;163(3):771-81. This retrospective analysis demonstrated rebleeding prior to aneurysm repair occurred in 9.7% of 544 patients, increased with SAH severity, and occurred more often during surgical repair outside regular working hours.","DOI":"10.1007\/s00701-020-04673-3"},{"key":"1199_CR11","doi-asserted-by":"publisher","unstructured":"\u2022 Rahmanian A, Derakhshan N, Sisakht AM, Ziarati NK, Shahraki HR, Motamed S. Risk factors for unfavorable outcome in aneurysmal subarachnoid hemorrhage revisited; odds and ends. Bulletin of Emergency & Trauma. 2018;6(2):133. https:\/\/doi.org\/10.1007\/s00701-020-04673-3. This article highlights that higher age, ischemic heart disease, duration of aneurysmal repair surgery, and amount of bleeding increase the odds of unfavorable outcomes.","DOI":"10.1007\/s00701-020-04673-3"},{"issue":"6","key":"1199_CR12","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. 2012;43(6):1711\u201337. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839.","journal-title":"Stroke"},{"key":"1199_CR13","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Lu VM, Graffeo CS, Perry A, Carlstrom LP, Rangel-Castilla L, Lanzino G, et al. Rebleeding drives poor outcome in aneurysmal subarachnoid hemorrhage independent of delayed cerebral ischemia: a propensity-score matched cohort study. J Neurosurg 2019;133(2):360-8. https:\/\/doi.org\/10.3171\/2019.4.JNS19779. This study demonstrated that rebleeding and delayed cerebral ischemia negatively impacts overall functional outcome and early rebleeding did not significantly affect the risk of delayed ischemic complications.","DOI":"10.3171\/2019.4.JNS19779"},{"key":"1199_CR14","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Galea JP, Dulhanty L, Patel HC, UK and Ireland Subarachnoid Hemorrhage Database Collaborators. Predictors of outcome in aneurysmal subarachnoid hemorrhage patients: observations from a multicenter data set. Stroke 2017;48(11):2958\u201363. https:\/\/doi.org\/10.1161\/STROKEAHA.117.017777. This article highlights earlier initiation of intensive blood pressure-lowering treatment provides greater protection against hematoma growth in acute intracerebral hemorrhage.","DOI":"10.1161\/STROKEAHA.117.017777"},{"key":"1199_CR15","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Liu G, Guo Z, Sun X, Chai W, Qi L, Li H, et al. Monitoring of the effect of cerebral autoregulation on delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. World Neurosurg 2018;118:e269-75.\u00a0https:\/\/doi.org\/10.1016\/j.wneu.2018.06.170. This study showed cerebral autoregulation monitored by near-infrared spectroscopy was impaired in poor grade SAH patients. Older age, smoking, hypertension, and especially impaired autoregulation are independent risk factors for delayed cerebral ischemia.","DOI":"10.1016\/j.wneu.2018.06.170"},{"key":"1199_CR16","doi-asserted-by":"publisher","unstructured":"\u2022 Gaasch M, Schiefecker AJ, Kofler M, Beer R, Rass V, Pfausler B, et al. Cerebral autoregulation in the prediction of delayed cerebral ischemia and clinical outcome in poor-grade aneurysmal subarachnoid hemorrhage patients. Crit Care Med 2018;46(5):774-80. https:\/\/doi.org\/10.1097\/CCM.0000000000003016. This article highlights higher initial pressure reactivity index was associated with delayed cerebral ischemia and worse clinical outcome in poor grade SAH patients.","DOI":"10.1097\/CCM.0000000000003016"},{"key":"1199_CR17","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Yu Z, Zheng J, Ma L, Li H, You C, Jiang Y. Predictive value of cerebral autoregulation impairment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a meta-analysis. World Neurosurg 2019;126:e853-9. https:\/\/doi.org\/10.1016\/j.wneu.2019.02.188. This meta-analysis shows impaired cerebral autoregulation has a sensitivity of 0.79 and specificity of 0.85 for delayed cerebral ischemia, with an area under ROC curve of 0.87.","DOI":"10.1016\/j.wneu.2019.02.188"},{"issue":"11","key":"1199_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","volume":"375","author":"AI Qureshi","year":"2016","unstructured":"Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1603460.","journal-title":"N Engl J Med"},{"issue":"25","key":"1199_CR19","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","volume":"368","author":"CS Anderson","year":"2013","unstructured":"Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355\u201365. https:\/\/doi.org\/10.1056\/NEJMoa1214609.","journal-title":"N Engl J Med"},{"issue":"5","key":"1199_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(08)70069-3","volume":"7","author":"CS Anderson","year":"2008","unstructured":"Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(08)70069-3.","journal-title":"Lancet Neurol"},{"key":"1199_CR21","doi-asserted-by":"publisher","unstructured":"\u2022 Chung P-W, Kim J-T, Sanossian N, Starkmann S, Hamilton S, Gornbein J, et al. Association between hyperacute stage blood pressure variability and outcome in patients with spontaneous intracerebral hemorrhage. Stroke 2018;49(2):348\u201354. https:\/\/doi.org\/10.1161\/STROKEAHA.117.017701. This prospective study illustrates blood pressure variability during the hyperacute first minutes and hours after onset in patients with intracerebral hemorrhage was independently associated with poor functional outcome.","DOI":"10.1161\/STROKEAHA.117.017701"},{"key":"1199_CR22","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Yang M, Pan X, Liang Z, Huang X, Duan M, Cai H, et al. Association between blood pressure variability and the short-term outcome in patients with acute spontaneous subarachnoid hemorrhage. Hypertens Res 2019;42(11):1701-7. https:\/\/doi.org\/10.1038\/s41440-019-0274-y. This study showed that blood pressure variability within the first 24 hours was independently associated with worse outcomes in SAH, with higher variability leading to worse outcomes.","DOI":"10.1038\/s41440-019-0274-y"},{"key":"1199_CR23","doi-asserted-by":"publisher","unstructured":"Tang C, Zhang T-S, Zhou L-F. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis. PLoS One 2014;9(6):e99536. https:\/\/doi.org\/10.1371\/journal.pone.0099536.","DOI":"10.1371\/journal.pone.0099536"},{"issue":"8","key":"1199_CR24","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.jocn.2015.02.024","volume":"22","author":"M Oheda","year":"2015","unstructured":"Oheda M, Inamasu J, Moriya S, Kumai T, Kawazoe Y, Nakae S, et al. Early rebleeding in patients with subarachnoid haemorrhage under intensive blood pressure management. J Clin Neurosci. 2015;22(8):1338\u201342. https:\/\/doi.org\/10.1016\/j.jocn.2015.02.024.","journal-title":"J Clin Neurosci"},{"key":"1199_CR25","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Maher M, Schweizer TA, Macdonald RL. Treatment of spontaneous subarachnoid hemorrhage: guidelines and gaps. Stroke 2020;51(4):1326-32. https:\/\/doi.org\/10.1161\/STROKEAHA.119.025997. This article reviews advancements in SAH treatment. Major illustrations include advances in neuroimaging improving diagnostic capabilities, nimodipine and endovascular aneurysm repair are the only treatments based on high-level evidence, and application of artificial intelligence in SAH research.","DOI":"10.1161\/STROKEAHA.119.025997"},{"key":"1199_CR26","doi-asserted-by":"publisher","unstructured":"Lin Q-S, Ping-Chen, Lin Y-X, Lin Z-Y, Yu L-H, Dai L-S, et al. Systolic blood pressure variability is a novel risk factor for rebleeding in acute subarachnoid hemorrhage: a case\u2013control study. Medicine (Baltimore) 2016;95(11):e3028. https:\/\/doi.org\/10.1097\/MD.0000000000003028.","DOI":"10.1097\/MD.0000000000003028"},{"key":"1199_CR27","doi-asserted-by":"publisher","unstructured":"\u2022 Marcolini E, Hine J. Approach to the diagnosis and management of subarachnoid hemorrhage. West J Emerg Med 2019;20(2):203-11. https:\/\/doi.org\/10.5811\/westjem.2019.1.37352. This review article summarizes strategies in diagnosing aneurysmal SAH as well as approaches to its management.","DOI":"10.5811\/westjem.2019.1.37352"},{"issue":"2","key":"1199_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12028-008-9057-z","volume":"9","author":"X Liu-Deryke","year":"2008","unstructured":"Liu-Deryke X, Janisse J, Coplin WM, Parker D, Norris G, Rhoney DH. A comparison of nicardipine and labetalol for acute hypertension management following stroke. Neurocrit Care. 2008;9(2):167\u201376. https:\/\/doi.org\/10.1007\/s12028-008-9057-z.","journal-title":"Neurocrit Care"},{"key":"1199_CR29","unstructured":"PubChem Compound Summary for CID 4474, Nicardipine [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004- [cited 2022 Jan 27]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Nicardipine."},{"key":"1199_CR30","unstructured":"PubChem Compound Summary for CID 153994, Clevidipine [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004- [cited 2022 Jan 27]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Clevidipine."},{"key":"1199_CR31","unstructured":"PubChem Compound Summary for CID 3869, Labetalol [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004- [cited 2022 Jan 27]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Labetalol."},{"key":"1199_CR32","doi-asserted-by":"publisher","unstructured":"\u2022 Hecht JP, Mahmood SM, Brandt M-M. Safety of high-dose intravenous labetalol in hypertensive crisis. Am J Health Syst Pharm 2019;76(5):286-92. https:\/\/doi.org\/10.1093\/ajhp\/zxy045. This retrospective study showed high-dose intravenous labetalol rarely caused clinically significant hemodynamic compromise and was not associated with adverse events.","DOI":"10.1093\/ajhp\/zxy045"},{"key":"1199_CR33","doi-asserted-by":"publisher","unstructured":"\u2022 El-Ghoroury H, Sudekum DM, Hecht JP. Blood pressure control in acute stroke: labetalol or nicardipine?. J Stroke Cerebrovasc Dis 2021;30(9):105959. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105959. This article highlights that no significant difference was observed between labetalol and nicardipine in percent time at BP goal or BP variability. Nicardipine was associated with significant tachycardia, while labetalol was associated with hypotension and bradycardia that was not significant.","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105959"},{"key":"1199_CR34","unstructured":"Herman LL, Bruss ZS, Tivakaran VS. Hydralazine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan- [updated 2021 Jul 26; cited 2022 Jan 27]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470296\/."},{"key":"1199_CR35","unstructured":"Holme MR, Sharman T. Sodium Nitroprusside. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan- [updated 2021 Jun 29; cited 2022 Jan 27]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557487\/."},{"issue":"6","key":"1199_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12975-016-0480-8","volume":"7","author":"T Garton","year":"2016","unstructured":"Garton T, Keep RF, Wilkinson DA, Strahle JM, Hua Y, Garton HJL, et al. Intraventricular hemorrhage: the role of blood components in secondary injury and hydrocephalus. Transl Stroke Res. 2016;7(6):447\u201351. https:\/\/doi.org\/10.1007\/s12975-016-0480-8.","journal-title":"Transl Stroke Res"},{"key":"1199_CR37","doi-asserted-by":"publisher","first-page":"8584753","DOI":"10.1155\/2017\/8584753","volume":"2017","author":"S Chen","year":"2017","unstructured":"Chen S, Luo J, Reis C, Manaenko A, Zhang J. Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment. BioMed Res Int. 2017;2017:8584753. https:\/\/doi.org\/10.1155\/2017\/8584753.","journal-title":"BioMed Res Int"},{"key":"1199_CR38","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Catapano JS, Ducruet AF, Frisoli FA, Nguyen CL, Louie CE, Labib MA, et al. Predictors of the development of takotsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage and outcomes in patients with intra-aortic balloon pumps. J Neurosurg 2020:1-6. https:\/\/doi.org\/10.3171\/2020.5.JNS20536. This article described that akotsubo cardiomyopathy after SAH occurs more often in female patients with large aneurysms, poor clinical grades, and clinical vasospasm. These patients have significantly worse neurological outcomes even with the use of an intra-aortic balloon pump.","DOI":"10.3171\/2020.5.JNS20536"},{"key":"1199_CR39","doi-asserted-by":"publisher","unstructured":"\u2022 Dinh DD, Lidington D, Kroetsch JT, Ng C, Zhang H, Nedospasov SA, et al. Experimental subarachnoid hemorrhage drives catecholamine-dependent cardiac and peripheral microvascular dysfunction. Front Physiol 2020;11:402. https:\/\/doi.org\/10.3389\/fphys.2020.00402. This study observed that elevated catecholamine levels in SAH stun the myocardium, reduce cardiac output, and augment myogenic vasoconstriction in isolated cremaster arteries. These cardiac and vascular effects are driven by beta- and alpha-adrenergic receptor signaling, respectively. Also found that tumor necrosis factor (TNF) gene deletion prevents the augmentation of myogenic reactivity in SAH.","DOI":"10.3389\/fphys.2020.00402"},{"key":"1199_CR40","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Norberg E, Odenstedt-Herges H, Rydenhag B, Oras J. Impact of acute cardiac complications after subarachnoid hemorrhage on long-term mortality and cardiovascular events. Neurocrit Care 2018;29(3):404-12. https:\/\/doi.org\/10.1007\/s12028-018-0558-0. This study showed that cardiac troponin, NT-proBNP, and ST-segment abnormalities were independently associated with an increased risk of death in SAH.","DOI":"10.1007\/s12028-018-0558-0"},{"key":"1199_CR41","doi-asserted-by":"publisher","unstructured":"\u2022 Suwatcharangkoon S, De Marchis GM, Witsch J, Meyers E, Velazquez A, Falo C, et al. Medical treatment failure for symptomatic vasospasm after subarachnoid hemorrhage threatens long-term outcome. Stroke 2019;50(7):1696-702. https:\/\/doi.org\/10.1161\/STROKEAHA.118.022536. This article illustrates that failure to respond to induced hypertension for symptomatic vasospasm increases risk of death and disability in SAH. Patients with symptomatic vasospasm and elevated troponin I levels are twice as likely to develop delayed cerebral ischemia.","DOI":"10.1161\/STROKEAHA.118.022536"},{"issue":"4","key":"1199_CR42","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","volume":"42","author":"MD Vergouwen","year":"2011","unstructured":"Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42(4):924\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.110.597914.","journal-title":"Stroke"},{"issue":"12","key":"1199_CR43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00234-009-0575-y","volume":"51","author":"JW Dankbaar","year":"2009","unstructured":"Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJH, Rinkel GJE. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51(12):813\u20139. https:\/\/doi.org\/10.1007\/s00234-009-0575-y.","journal-title":"Neuroradiology"},{"issue":"6","key":"1199_CR44","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/STROKEAHA.108.544700","volume":"40","author":"JA Frontera","year":"2009","unstructured":"Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?. Stroke. 2009;40(6):1963\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.108.544700.","journal-title":"Stroke"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01199-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-022-01199-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01199-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T13:15:18Z","timestamp":1659791718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-022-01199-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1199"],"URL":"https:\/\/doi.org\/10.1007\/s11906-022-01199-0","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"15 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"W. Denney Zimmerman and Wan-Tsu W. Chang declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}